Have Complications Related to Balloon Pulmonary Angioplasty Changed Since its Inception?

Balloon pulmonary angioplasty: Evolution over time and its complications


Balloon pulmonary angioplasty (BPA) has grown from its beginnings as an indication for patients with chronic thromboembolic pulmonary hypertension (CTEPH) to being currently a class 1 indication for inoperable patients and/or residual CTEPH. Current evidence on this topic is underpowered, as most reports are based on a small number of patients.

¿Han cambiado las complicaciones relacionadas a la angioplastia pulmonar con balón desde sus inicios? 

Researchers conducted a systematic review on papers reporting on BPA and its results. In addition, the rate of complications related to BPA was analyzed for two time periods, 2013-2017 and 2018-2022. 

The primary endpoint (PEP) was the incidence of BPA-related complications, defined as vessel injury or hemoptysis, use of mechanical ventilation, or procedure-related death.

The analysis included a total of 1714 CTEPH patients, who accounted for a total of 7561 BPA sessions. The mean follow-up was 7.3 months after the procedure. Results showed that the incidence of hemoptysis or vessel injury was 11.1%, the rate of reperfusion edema was 6%, the rate of mechanical ventilation was 0.4%, and the mortality rate was 1.3%.

Read also: AQCA Study: Pre-PCI Virtual QFR for Planning PCI vs. Conventional Angiography.

When complications were analyzed over the two time periods, the cumulative incidence of hemoptysis and vessel injury decreased from 14.1% to 7.7% (p < 0.01), reperfusion edema decreased from 11.3% to 1.4% (p < 0.01), mechanical ventilation decreased from 0.7% to 0.1% (p < 0.01), and even mortality decreased from 2% to 0.8% (p < 0.01).

Conclusion

BPA is running its natural course, becoming a safe procedure as time goes by. Further research is needed to improve procedural technique, patient selection, and treated lesion characteristics.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Periprocedural Complications With Balloon Pulmonary Angioplasty Analysis of Global Studies 

Reference: Nishant Jain, MD et al J Am Coll Cardiol Intv 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...

J-Valve for Chronic AR: 30-Day Outcomes of Transfemoral Valve J-Valve in Chronic Aortic Regurgitation

Chronic aortic regurgitation (AR) poses a significant challenge as far as transcatheter alternatives go due to the absence of calcification and a suitable anchoring...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...